Termine
Präsentationen
Aktie
Aktueller Finanzbericht
News
Neueste
Tweets
vor 20 Stunden 36 Minuten
@MorphoSys
We’re thrilled to be a part of the upcoming #ASH2020 Annual Meeting - visit our pre-ASH virtual booth to learn mor… https://t.co/TP76sz2epb
vor 1 Tag 2 Stunden
@MorphoSys
We are delighted to welcome @tobiegi as our new head of corporate communications. Thomas will play a key role in ra… https://t.co/cSMhcF2J10
vor 2 Tage 8 Stunden
@MorphoSys
The MorphoSys BD&L team looks forward to participating in virtual #HealthcarePartneringWeek from January 11-15, 202… https://t.co/0SLWUwF3Bs
vor 1 Woche 23 Stunden
@MorphoSys
During our #ComplianceWeek we at #MorphoSys unite under the motto #IntegrityInAllWeDo. From Research & Development… https://t.co/w1aVlLQwRX
vor 1 Woche 5 Tage
@MorphoSys
It is #ComplianceWeek at #MorphoSys and our employees in Germany and the US have come together for a week full of e… https://t.co/shCKBWrUYe
vor 2 Wochen 23 Stunden
@MorphoSys
At #MorphoSys we’re celebrating #ComplianceWeek, uniting under the motto “Integrity in all we do”. Acting with… https://t.co/WpwZfzoeNp
vor 2 Wochen 6 Tage
@MorphoSys
MorphoSys and Cherry Biolabs signed a multi-target licensing agreement granting #MorphoSys the rights to apply Cher… https://t.co/44g6yXI2sk
vor 2 Wochen 6 Tage
@MorphoSys
MorphoSys, together with its partners Xencor and @Incyte, announced a Global Development Collaboration aiming to he… https://t.co/qDgoQLDZyE
vor 3 Wochen 2 Stunden
@MorphoSys
We’ve reported our Nine Months and Third Quarter 2020 Results including Corporate and Program Updates.… https://t.co/0jPpdh9Sj5
Investorenkontakt
Dr. Julia Neugebauer
Director Investor Relations
Telefon +49 89 89927 179
Myles Clouston
Senior Director, Head of US Investor Relations
Telefon +1 857 772 0240
Medienkontakt
Thomas Biegi
Vice President, Head of Corporate Communications
Telefon +49 89 89927 26079
Sophie Petersen
Senior Specialist Corporate Communications
Telefon +49 89 89927 26033
Fax: +49 89 89927 526033